What is Starrett Podiatry?
Starrett Podiatry operates as a premier provider of comprehensive foot and ankle care, serving diverse patient populations across Brooklyn, the Bronx, and New York City. The practice distinguishes itself through a multidisciplinary approach to podiatric medicine, addressing complex conditions ranging from chronic arthritis and bunion deformities to specialized diabetic foot management and sports-related trauma. With a legacy spanning over 30 years, the organization integrates evidence-based research with advanced clinical technology to deliver high-quality outcomes. Its market position is anchored in a commitment to compassionate, accessible healthcare, making it a vital component of the regional medical infrastructure. The firm's ability to secure substantial late-stage capital underscores its stability and the growing demand for specialized podiatric interventions in urban environments.
How much funding has Starrett Podiatry raised?
Starrett Podiatry has raised a total of $487K across 2 funding rounds:
Debt
$150K
Debt
$337K
Debt (2020): $150K with participation from PPP
Debt (2021): $337K led by PPP
Key Investors in Starrett Podiatry
PPP
Public-Private Partnership
What's next for Starrett Podiatry?
With the recent influx of capital, Starrett Podiatry is poised to accelerate its strategic growth initiatives. The organization is expected to prioritize the expansion of its physical locations and the integration of next-generation diagnostic tools to enhance patient throughput and treatment efficacy. By optimizing its clinical workflows and broadening its service reach, the practice aims to solidify its leadership in the New York podiatry market. Future developments will likely focus on scaling administrative efficiencies and deepening its investment in specialized medical talent, ensuring that the firm remains at the forefront of podiatric innovation while meeting the evolving needs of its patient base.
See full Starrett Podiatry company page